SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. It operates through the United States and International geographical segments. The firm offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

Trade Desk is facing extreme bearish sentiment and high volatility as investors brace for an earnings report that follows a streak of poor post-earnings price action. The community is sharply divided, with some hoping for a short squeeze or a potential OpenAI partnership catalyst, while many others are expressing deep frustration over the stock's long-term downtrend and a perceived lack of clear communication from leadership.

Opendoor Technologies, Inc. engages in the operation of buying, selling, and trading of residential properties online. The company was founded by Eric Wu on December 30, 2013, and is headquartered in Tempe, AZ.

Opendoor Technologies Inc

Opendoor Technologies is trending as investors scrutinize the company's latest quarterly results, with the community sharply divided between those praising management's turnaround strategy and critics highlighting ongoing losses and cash burn. The conversation is heavily focused on the company's path to profitability and whether its operational improvements can overcome the challenges of a difficult housing macro environment.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending following the filing of a lawsuit against NS Pharma, which investors view as a strategic move to potentially regain full distribution rights and enhance the company's valuation ahead of an imminent FDA decision. While the legal uncertainty has introduced short-term volatility, the community is focused on the potential for a more lucrative partnership or independent commercialization path that could significantly increase long-term upside.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, Peter Salanki, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is facing significant volatility following earnings as investors weigh a massive revenue backlog against wider-than-expected losses and rising capital expenditures. The community is sharply divided between those betting on long-term hyperscaler growth and others concerned that aggressive infrastructure spending and debt levels signal a bubble.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is trending as investors react to mixed quarterly earnings and aggressive volatility, while the community remains hyper-focused on the company's expanding backlog and potential for massive utility-scale demand from hyperscale data center projects. Despite recent price pressure and analyst skepticism regarding margins, long-term holders are debating whether to accumulate more shares in anticipation of a structural re-rating tied to global grid storage needs.

IREN Ltd. is a vertically integrated data center business powering the future of Bitcoin, AI and beyond with renewable energy. It is strategically located in renewable-rich, fiber-connected regions across the US and Canada. IREN’s large-scale, grid-connected facilities are purpose-built for the next generation of power-dense computing applications. The company was founded by Daniel Roberts and William Roberts on November 6, 2018, and is headquartered in Sydney, Australia.

IREN Ltd.

IREN Limited

IREN is seeing intense volatility following a strategic partnership announcement with NVIDIA, which includes a multi-year cloud services contract and warrants that allow NVIDIA to purchase shares at a set price. While retail investors are reacting with enthusiasm to the institutional backing, the stock is experiencing significant pressure as the community digests the company's latest earnings report, sparking heated debate over fundamental performance versus long-term infrastructure potential.

Phoenix Asia Holdings Ltd. engages in the substructure works and other construction services. It offers site formation, ground investigation and foundation work through it subsidiary. The company was founded on August 9, 2024 and is headquartered in Hong Kong.

Phoenix Asia Holdings Ltd.

Phoenix Asia Holdings is experiencing extreme volatility driven by speculative retail interest in low-float Chinese stocks and high-frequency day trading activity. The community is sharply divided, with some traders hunting for explosive squeezes and massive gains, while others caution against what they perceive as a volatile pump-and-dump scheme plagued by frequent trading halts.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is surging following a record-breaking first quarter, fueled by accelerating enterprise AI demand and a significant new deal that signals strong forward growth. The community is actively discussing the potential for a short squeeze driven by heavy short interest and institutional FOMO as the company establishes itself as a leader in AI data infrastructure.

HubSpot, Inc. engages in cloud-based customer relationship management. Its platform includes marketing, sales, service, operations and content management systems, as well as other tools, integrations, and native payment solutions. The company was founded by Brian Patrick Halligan and Dharmesh Shah on April 4, 2005, and is headquartered in Cambridge, MA.

HubSpot Inc

HubSpot is experiencing extreme volatility and heavy selling pressure as investors grapple with fears that generative AI could disrupt its core SaaS business model. While the company recently delivered a double beat and authorized a significant share buyback, community sentiment remains sharply divided between those viewing the decline as a major buying opportunity and those concerned that AI-driven automation will permanently erode the company's competitive moat.

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Atara Biotherapeutics Inc

Atara Biotherapeutics is trending following a significant FDA regulatory update concerning the resubmission path for its therapy, tabelecleucel, which has fueled intense debate among traders regarding the company's long-term financial viability and future clinical strategy. While bulls see an opportunity for a recovery play following the FDA's clarification, bears remain focused on the company's tight cash runway and the uncertainty surrounding the required additional patient data for approval.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
